تداخل‌های دارویی
Erdafitinib + Sevelamer
شدت: متوسط
Erdafitinib and Sevelamer: moderate interaction.
آخرین به‌روزرسانی
ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.
محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.
خلاصه
Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
معنای این تداخل به زبان ساده
Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Erdafitinib belongs to Oncology; Sevelamer belongs to Miscellaneous.
چرا رخ می‌دهد
Pharmacodynamic confounding: sevelamer binds dietary phosphate and lowers serum phosphate, obscuring the phosphate response used to titrate erdafitinib.
اقدام لازم
Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
از داروساز چه بپرسید
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
ویژه اعضای Pro+
باز کردن کل صفحه
یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Erdafitinib و Sevelamer، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.
تداخلات دیگر Sevelamer
تداخلات دیگر Erdafitinib
پرسش‌های متداول
Can I take Erdafitinib with Sevelamer?
MediHelp rates the interaction as moderate. Erdafitinib and Sevelamer can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erdafitinib raises serum phosphate as an expected effect of FGFR inhibition, and this level guides dose escalation during the first weeks of treatment. A phosphate binder such as sevelamer can mask this rise and lead to inappropriate dosing decisions.
How serious is the interaction between Erdafitinib and Sevelamer?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid phosphate binders during the first 21 days of erdafitinib so the phosphate-guided dose titration is reliable. Afterward, use binders only if hyperphosphatemia needs management according to labeling.
What other medicines interact with Sevelamer?
MediHelp also lists interactions of Sevelamer with, for example, Carbamazepine, Ciprofloxacin, Dichlorphenamide. The full list is on the Sevelamer page.
تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp
مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.
